BusinessKorea

Samsung Bioepis Secures PH20 SC Formulation Platform

Samsung Bioepis is accelerating its push into the next-generation biosimilar market after independently securing a core ...
clinicaladvisor.com

Subcutaneous Efgartigimod PH20 Shows Efficacy in Myasthenia Gravis

Efgartigimod given subcutaneously with hyaluronidase PH20 is as effective as IV efgartigimod in reducing total IgG levels, preliminary findings show. PHOENIX, Arizona—Efgartigimod given subcutaneously ...
Yahoo Finance

Coherent Introduces New PH20 SmartWeld+ Laser Processing Heads for Precision Welding at High Speeds in EV Applications

PITTSBURGH, June 14, 2023 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a leader in advanced laser processing solutions, today introduced its new PH20 SmartWeld+ laser processing heads optimized ...
生物通

经过PH20修饰的外泌体载有姜黄素，通过破坏细胞外基质屏障并使癌相关成纤维细胞恢复正常功能，从而抑制脱屑性乳腺癌的生长

本研究设计了一种工程化外泌体递送系统Exos-PH20@Cur，通过结合透明质酸酶PH20降解纤维化基质中的透明质酸，以及姜黄素Cur的靶向递送，突破三阴性乳腺癌（TNBC）的纤维化肿瘤微环境（TME ...
Medscape

First New Treatment in 30 Years for Rare Disease Effective, Tolerable, Convenient

PHOENIX — Subcutaneous efgartigimod PH20 SC shows efficacy and tolerability in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), providing a convenient alternative to ...

[단독] 삼성에피스 ‘빅파마 독점’ 고용량 SC 기술 성공

글로벌 1위 항암제 키트루다 등시밀러 진입 막는 특허장벽 뚫어물질·배양·정제 모두 독자 구축 삼성에피스홀딩스(0126Z0)의 자회사 삼성바이오에피스가 재조합 인간 히알루로니다제(PH20) 기반 피하주사(SC) 제형 변경 ...

[단독] 알테오젠 "키트루다 SC, 복제약과 경쟁 가능성 없다"

이 기사는 7월 15일 오후 2시57분 한국경제신문의 투자 정보 유료 플랫폼인 '한경 프리미엄9'(www.hankyung.com/premium9)에 게재됐습니다. 한경 프리미엄9을 구독하시면 더 많은 단독 기사를 실시간으로 ...
L'Usine Nouvelle

PH20 - tête de palpage motorisée 5 axes à déclenchement par contact.

“ La PH20 est une tête de palpage dynamique qui divise par trois les temps de mesure tout en conservant une précision élevée. En exploitant la technologie mise au point pour le système de mesure REVO® ...